We are proud to celebrate our 2026 NUZYRA® and XHANCE® Circle of Excellence Award winners – individuals who lead with purpose, elevate those around them, deliver meaningful impact to patients, and continue to propel our business forward. Their contributions set the standard for excellence across our organization. #ParatekProud
Paratek Pharmaceuticals
Pharmaceutical Manufacturing
Boston, MA 22,095 followers
Developing transformative solutions for patients with infectious diseases and other difficult to treat conditions
About us
Positive Outcomes. Positive Patient Stories®. These are our priorities at Paratek Pharmaceuticals. As a commercial-stage biopharmaceutical company, we develop transformative solutions for patients with infectious diseases and other difficult to treat conditions, and we believe that we have the right people, the right knowledge and the right drug to make a difference in patients’ lives. Our Mission To create positive stories for patients, physicians and caregivers based on trust and integrity. To accomplish this, our employees work hard to turn everyday decisions into everyday triumphs that advance our technology and strengthen Paratek. Our Vision To be a leading independent biopharmaceutical company providing novel life-saving products for life-threatening diseases or other public health threats.
- Website
-
http://www.paratekpharma.com
External link for Paratek Pharmaceuticals
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Boston, MA
- Type
- Privately Held
- Founded
- 1996
Locations
-
Primary
Get directions
75 Park Plaza
4th Floor
Boston, MA 02116, US
-
Get directions
1000 First Avenue
Suite 200
King of Prussia, PA 19406, US
Employees at Paratek Pharmaceuticals
Updates
-
We’re on the ground at the Special Operations Medical Association Scientific Assembly this week in Raleigh. If you’re attending, come visit us at Booth 940. #SOMA2026
-
-
Today is Global CRSwNP Awareness Day, an opportunity to raise awareness of chronic rhinosinusitis with nasal polyp syndrome and bring the community together to advance understanding and education. CRSwNP is a chronic inflammatory disease that can significantly impact quality of life and is often linked with conditions like asthma and allergies. Increasing awareness can help individuals recognize symptoms earlier, support more informed conversations with healthcare providers, and help improve care over time. Join the conversation (#LetsTalkCRS) and learn more from EUFOREA - European Forum for Research and Education in Allergy and Airway Diseases: https://bit.ly/42kABqi
-
-
As we celebrate Administrative Professionals Day, we recognize the people who help keep our work moving forward in meaningful ways. Across Paratek, administrative professionals play a key role in keeping our teams connected, priorities organized, and critical details on track. Their coordination and follow-through help enable strong execution across the organization. We appreciate the consistency, care, and commitment they bring every day. Thank you for all you do.
-
-
Paratek continues to advance the science in areas of high unmet need in infectious diseases. At #ESCMIDGlobal2026, the annual Congress of ESCMID - European Society of Clinical Microbiology and Infectious Diseases, we’ll present new data from clinical, non-clinical, and real-world studies. We’re also proud to support investigator-sponsored research that helps deepen understanding and inform care. Read today’s announcement and explore the full list of our presentations: https://bit.ly/4ea1Fjt
-
-
The 2026 Vivli AMR Surveillance Data Challenge is now open. We are proud to support this global effort that connects the research community with high-quality surveillance data to deepen understanding of antimicrobial resistance and help drive solutions where they’re needed most. Researchers around the world are invited to apply by May 26. Learn more and submit your expression of interest: https://bit.ly/4cjL224
The 2026 Vivli AMR Surveillance Data Challenge is now open. Researchers can apply for access to high-quality AMR surveillance datasets from Pfizer, Shinogi, Johnson & Johnson, Paratek Pharmaceuticals, and others — to tackle some of the most pressing questions in antimicrobial resistance. Funded by the Global AMR R&D Hub, Pfizer Inc, Paratek Pharmaceuticals, Johnson & Johnson, an NIH award, and Vivli. Last year: 58 teams. 22 countries. 6 winners. Expression of interest deadline: May 26, 2026. Applications are now open worldwide. Apply at https://lnkd.in/ey7VcvGH
-
-
As National Public Health Week draws to a close, we recognize the tireless efforts of those working to protect and improve community health. We are committed to advancing treatment options that support public health and safety, and we proudly support the American Public Health Association’s mission to champion the health of all people and all communities: https://bit.ly/4e8gNO1 #NPHW
-
-
Antimicrobial resistance remains one of the most pressing global health threats and advancing new solutions will require sustained innovation and collaboration across the healthcare ecosystem. Our CEO, Dr. Evan Loh, recently sat down with Roland Pease and the BBC Discovery team to discuss the economic realities shaping antibiotic development and the future of antimicrobial innovation. Listen to their conversation (starting at 9:15) in the latest episode of Superbugs: Resistance Rising: https://bit.ly/3PVdLCQ
-
We’re onsite in Charlotte, NC, for the Symposium on Advanced Wound Care & Wound Healing Society Spring meeting, April 8-11. As the field continues to evolve, effective infection management remains a cornerstone of wound healing and improved patient outcomes. Find the Paratek team at booth #1325 – we’d love to connect. Stop by to meet the team and discuss the latest research and advances in wound care. #SAWCSpring #WHS2026
-
-
We were honored to welcome U.S. Representative Madeleine Dean to our Pennsylvania offices this week. Congresswoman Dean spent time with our team learning more about the science behind our work and the momentum we're building across our pipeline. The discussion underscored a shared focus on scientific leadership and future growth. We’re proud to showcase the innovation happening here and the role we play in advancing new therapeutic options for patients and HCPs, while contributing to the strength of our local community. Thank you, Congresswoman Dean, for your engagement, support, and recognition of the importance of a thriving biotech ecosystem in Southeast Pennsylvania.
-